понедельник, 11 апреля 2016 г.

Valeant has told outgoing CEO to cooperate with Senate

Valeant has told outgoing CEO to cooperate with Senate


Valeant Pharmaceuticals asked its CEO to cooperate with a Senate investigation into drug pricing after he failed to appear for a deposition. The Senate Special Committee on Aging said last week that it planned to start legal proceedings against J. Michael Pearson, who is leaving Valeant.



from Biotech News